Search Results - "O'Morain, C. A."

Refine Results
  1. 1

    Review article: the effects of antitumour necrosis factor‐α on bone metabolism in inflammatory bowel disease by Veerappan, S. G., O’Morain, C. A., Daly, J. S., Ryan, B. M.

    Published in Alimentary pharmacology & therapeutics (01-06-2011)
    “…Summary Background  Patients with inflammatory bowel disease (IBD) are at increased risk of osteoporosis. A number of studies have emerged in recent years…”
    Get full text
    Journal Article
  2. 2

    Nutrition and adult inflammatory bowel disease by Goh, J., O'Morain, C. A.

    Published in Alimentary pharmacology & therapeutics (01-02-2003)
    “…Summary Major advances in the understanding of the aetio‐pathogenesis and genetics of inflammatory bowel disease have been accompanied by an escalation in the…”
    Get full text
    Journal Article
  3. 3

    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report by Malfertheiner, P, Megraud, F, O'Morain, C A, Gisbert, J P, Kuipers, E J, Axon, A T, Bazzoli, F, Gasbarrini, A, Atherton, J, Graham, D Y, Hunt, R, Moayyedi, P, Rokkas, T, Rugge, M, Selgrad, M, Suerbaum, S, Sugano, K, El-Omar, E M

    Published in Gut (01-01-2017)
    “…Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects…”
    Get more information
    Journal Article
  4. 4

    Significant psychological morbidity occurs in irritable bowel syndrome: a case‐control study using a pharmacy reimbursement database by CANAVAN, J. B., BENNETT, K., FEELY, J., O’MORÁIN, C. A., O’CONNOR, H. J.

    Published in Alimentary pharmacology & therapeutics (15-02-2009)
    “…Summary Background  Psychological problems are associated with IBS but the strength of this association is unclear. Aim  To assess co‐prescribing of…”
    Get full text
    Journal Article
  5. 5

    Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study by O'Sullivan, M A, O'Morain, C A

    Published in Digestive and liver disease (01-05-2000)
    “…Symptoms of at least a subgroup of patients with irritable bowel syndrome may be associated with an alteration in gut flora. Studies on bacterial based therapy…”
    Get full text
    Journal Article
  6. 6

    Review article: current therapeutic options for gastric antral vascular ectasia by Sebastian, S, O'Morain, C A, Buckley, M J M

    Published in Alimentary pharmacology & therapeutics (15-07-2003)
    “…Gastric antral vascular ectasia, or 'watermelon stomach', is a rare but important cause of gastrointestinal blood loss and anaemia, which has characteristic…”
    Get full text
    Journal Article
  7. 7

    Review article: nutrition and adult inflammatory bowel disease by Goh, J, O'Morain, C A

    Published in Alimentary pharmacology & therapeutics (01-02-2003)
    “…Major advances in the understanding of the aetio-pathogenesis and genetics of inflammatory bowel disease have been accompanied by an escalation in the…”
    Get full text
    Journal Article
  8. 8

    Treatment of Helicobacter pylori by Egan, B. J., Katicic, M., O'Connor, H. J., O'Morain, C. A.

    Published in Helicobacter (Cambridge, Mass.) (01-10-2007)
    “…Since the discovery of Helicobacter pylori in the early 1980s many treatment regimes have been developed to effectively treat this infection. International…”
    Get full text
    Journal Article
  9. 9

    Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practice by LEE, J. M, BRESLIN, N. P, HYDE, D. K, BUCKLEY, M. J, O'MORAIN, C. A

    Published in Alimentary pharmacology & therapeutics (01-04-1999)
    “…Background : The effectiveness of Helicobacter pylori eradication regimens has not been extensively investigated in the clinical practice setting. The optimal…”
    Get full text
    Journal Article
  10. 10

    Impact of Helicobacter pylori on the management of dyspepsia in primary care by BENNETT, K., FEELY, J., THORNTON, O., DOBSON, M., O'MORAIN, C. A., O'CONNOR, H. J.

    Published in Alimentary pharmacology & therapeutics (01-08-2006)
    “…Summary Background  It is unclear what impact Helicobacter pylori infection has had on the management of dyspepsia in primary care and to what extent published…”
    Get full text
    Journal Article
  11. 11

    Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding by LEE, J. M, BRESLIN, N. P, FALLON, C, O'MORAIN, C. A

    Published in The American journal of gastroenterology (01-05-2000)
    “…The eradication of Helicobacter pylori (H. pylori) in patients with bleeding peptic ulcer disease (PUD) decreases the rate of ulcer rebleeding. Although all…”
    Get full text
    Journal Article
  12. 12

    Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study by Mahmud, N, Kamm, M A, Dupas, J L, Jewell, D P, O'Morain, C A, Weir, D G, Kelleher, D

    Published in Gut (01-10-2001)
    “…BACKGROUND AND AIMS The benefit of 5-aminosalicylic acid therapy for maintenance of remission in Crohn's disease is controversial. The primary aim of this…”
    Get full text
    Journal Article
  13. 13

    Eradication of Helicobacter pylori Affects Symptoms in Non-Ulcer Dyspepsia by Gilvarry, J., Buckley, M. J. M., Beattie, S., Hamilton, H., O'morain, C. A.

    “…Background: The relationship between Helicobacter pylori infection and non-ulcer dyspepsia is controversial. Methods: In a prospective, long-term, double-blind…”
    Get full text
    Journal Article
  14. 14

    Computer-assisted propofol administration by O'Connor, J P A, O'Moráin, C A, Vargo, J J

    Published in Digestion (01-01-2010)
    “…The use of propofol for sedation in endoscopy may allow for better quality of sedation, quicker recovery and facilitate greater throughput in endoscopy units…”
    Get more information
    Journal Article
  15. 15

    Early diagnosis of bilateral sub-deltoid bursitis using clinic-based ultrasonography in a patient receiving infliximab therapy for ulcerative pouchitis by Veerappan, S. G., Moinuddin, G., Kennedy, M., O’Morain, C. A., Kane, D.

    Published in Irish journal of medical science (01-12-2010)
    “…Background Infliximab, a monoclonal chimeric antibody to tumour necrosis factor (TNF)α, is a novel therapy used in the management of chronic refractory…”
    Get full text
    Journal Article
  16. 16

    Use of Infliximab as rescue therapy in acute severe Ulcerative Colitis with recent norovirus infection by O'Connor, J P A, O'Moráin, C A, Neary, P, Breslin, N P

    Published in Journal of Crohn's and colitis (01-09-2009)
    “…Norovirus infection is a common cause of acute diarrhoeal illness and may occur in the setting of inflammatory bowel disease. A patient with an acute severe…”
    Get full text
    Journal Article
  17. 17

    What is new in the management of Helicobacter pylori? by Egan, B. J., O’Connor, H. J., O’Morain, C. A.

    Published in Irish journal of medical science (01-09-2008)
    “…Since the discovery of Helicobacter pylori in the early 1980s several treatment regimens have been developed to effectively treat this infection. International…”
    Get full text
    Journal Article
  18. 18

    Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results by Sebastian, S, McLoughlin, R, Qasim, A, O’Morain, C.A, Buckley, M.J

    Published in Digestive and liver disease (01-03-2004)
    “…Introduction. Gastric antral vascular ectasia is a rare but well-recognised cause of occult gastrointestinal bleeding. Various endoscopic treatments have been…”
    Get full text
    Journal Article
  19. 19

    Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice by Lee, J M, Deasy, E, O'Morain, C A

    “…Consensus guidelines recommend that patients with peptic ulcer disease, and other causes of dyspepsia, should be treated with Helicobacter pylori eradication…”
    Get more information
    Journal Article
  20. 20

    Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting by Xia, H X, Windle, H J, Marshall, D G, Smyth, C J, Keane, C T, O'Morain, C A

    Published in Gut (01-07-1995)
    “…The aim of this study was to find out if reinfection or recrudescence accounted for the recurrence of Helicobacter pylori infections after apparent eradication…”
    Get full text
    Journal Article